ADMA ADMA BIOLOGICS INC
2026Q1 · CUSIP 000899104 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
355
Δ holders QoQ
0
Breadth percentile
Top 62%
Whale holders
163
Δ whales
0
Inst. holding value
$1.9B
New positions
72
Closed positions
72
Price momentum (1Q)
-47.5%
Put / Call
6/10
Breadth history (34 quarters)
Past Lit Events & Aftermath 13 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q2 | Top 13% | -11.7% | -9.3% |
| 2025Q1 | Top 8% | -13.6% | -23.6% |
| 2024Q3 | Top 4% | -18.9% | +3.2% |
| 2024Q2 | Top 5% | +15.1% | -8.4% |
| 2024Q1 | Top 8% | +97.8% | +106.7% |
| 2023Q2 | Top 12% | -12.8% | +21.6% |
| 2022Q4 | Top 13% | +16.4% | +18.2% |
| 2022Q3 | Top 7% | +14.9% | +29.7% |
Options Sentiment
Put holders
6
QoQ: -2
Call holders
10
QoQ: +1
See methodology →
Fundamentals
PE (TTM)
12.9
EPS (TTM)
$0.68
EPS YoY
-19.1%
Revenue (TTM)
$0.5B
Revenue YoY
+11.0%
Net margin
32.4%
ROE
42.4%
Debt ratio
41.3%
FCF (TTM)
$108M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.